CN Stock MarketDetailed Quotes

Tianjin Lisheng Pharmaceutical (002393)

Watchlist
  • 15.94
  • +0.04+0.25%
Market Closed May 15 15:00 CST
4.92BMarket Cap11.93P/E (TTM)

Tianjin Lisheng Pharmaceutical (002393) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Tablet833.19M59.86%
Injection214.31M15.40%
Pills133.85M9.62%
Capsule131.2M9.43%
Other44.91M3.23%
Granule34.56M2.48%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing1.39B100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
North China579.59M41.64%
East China region322.92M23.20%
Central and southern region228.87M16.44%
Southwest area119.22M8.56%
Northwest region84.85M6.10%
Northeast area53.88M3.87%
Exit2.68M0.19%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More